Biogen Linked To More Coronavirus Cases In Boston
International Meeting At Center Of Outbreak
Executive Summary
Company has instructed employees and contractors to self isolate to prevent further spread of COVID-19.
You may also be interested in...
How COVID-19 Defined 2020 For Biopharma
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
From Early 2020 To Q3: Biogen Shifts Aducanumab Filing Expectations Again
The company remains confident in US FDA approval for the first disease-modifying Alzheimer’s drug based on current data, but Biogen needs more time to complete the BLA filing.
In A Volatile Time, Pharma Reassures Business Remains Steady
Amid a stock market freefall spurred largely by coronavirus uncertainty, big pharma sought to reassure investors and the public that supply disruptions are not an immediate concern and they are monitoring business operations day-by-day.